Anti-Human IL23A Therapeutic Antibody (Brazikumab)

Recombinant monoclonal antibody to IL23A. Brazikumab is a human monoclonal antibody that can be potentially used in the treatment of Crohn's disease (CD).
Supplier Creative Biolabs
Product # TAB-008ML
Pricing Inquiry
Host Human
Target IL23A
Species Reactivity Human
Type IgG2, λ
Applications ELISA, IHC, FC, IP, IF, Inhib, PK
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback